ArticleCommunications biology2024
SH3RF2 contributes to cisplatin resistance in ovarian cancer cells by promoting RBPMS degradation.
Ting-Ting Gong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it